related documents Are the Beneficial Cardiovascular Effects of Glucagon-Like Peptide 1 Receptor Agonists in Diabetic Patients Metabolically Mediated? Conferences Rivaroxaban Plus Aspirin versus With Aspirin in Patients With Prior Percutaneous Coronary Intervention (PCI): Insights From the COMPASS Trial Conferences
